BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 15, 2020
View Archived Issues
Immunocytokines jumpstart anti-glioblastoma immunity
Read More
Structural insights into small-molecule GLP-1 agonists
Read More
FDA clears IND for phase I/IIa study of AstroStem-V to treat COVID-19 patients with pneumonia
Read More
Enrollment begins in phase II ASUNCTIS study of asunercept in patients with COVID-19
Read More
NIH launches ACTIV-5/BET trial to identify new promising COVID-19 treatments
Read More
New osteoporosis treatment target, inhibitor identified
Read More
Universita degli Studi di Milano and collaborators describe inhibitors of miR-129
Read More
Cyclerion provides updates on their development of olinciguat and IW-6463
Read More
New MAP3K5 inhibitors identified at Enanta Pharmaceuticals
Read More
California Institute of Technology, 1200 Pharma and UC Oakland disclose PRMT5 inhibitors
Read More
Columbia University, Forkhead BioTherapeutics synthesize new FOXO1 inhibitors
Read More
New galectin-3 inhibitors discovered at Bristol Myers Squibb
Read More
Novan presents positive in vitro data for its NITRICIL platform technology against SARS-CoV-2
Read More
FDA grants approval for expanded use of Wakix for cataplexy in adult patients with narcolepsy
Read More
Sorrento cleared for phase II trial in Brazil of abivertinib for mild, moderate and severe COVID-19
Read More
Arvinas announces new preclinical programs
Read More
Janssen begins phase III evaluation of seltorexant as adjunctive therapy for MDD with insomnia
Read More
Astellas describes discovery of novel PET probe for fatty acid oxidation
Read More
First subject dosed in phase I study of AZP-3601
Read More
FDA clears IND for 177Lu-omburtamab-DTPA
Read More
KKC-080106 shows promising neuroprotective activity in preclinical models
Read More
Ankasa begins phase Ib/IIa evaluation of ART352-L in posterolateral spinal fusion
Read More
Roche begins phase III study of GDC-9545 with palbociclib in advanced breast cancer
Read More
FDA approves Inmazeb for Zaire ebolavirus
Read More
Vertex discontinues development of VX-814 for alpha-1 antitrypsin deficiency
Read More